Masoud Etemadifar

5.3k total citations
262 papers, 3.5k citations indexed

About

Masoud Etemadifar is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology. According to data from OpenAlex, Masoud Etemadifar has authored 262 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 159 papers in Pathology and Forensic Medicine, 84 papers in Neurology and 49 papers in Rheumatology. Recurrent topics in Masoud Etemadifar's work include Multiple Sclerosis Research Studies (151 papers), Peripheral Neuropathies and Disorders (49 papers) and Systemic Lupus Erythematosus Research (36 papers). Masoud Etemadifar is often cited by papers focused on Multiple Sclerosis Research Studies (151 papers), Peripheral Neuropathies and Disorders (49 papers) and Systemic Lupus Erythematosus Research (36 papers). Masoud Etemadifar collaborates with scholars based in Iran, United States and United Kingdom. Masoud Etemadifar's co-authors include Amir‐Hadi Maghzi, Mohsen Janghorbani, Seyed-Hossein Abtahi, Zahra Nasr, Amir Hadi Maghzi, Mojtaba Akbari, Alireza Minagar, Vahid Shaygannejad, Kamran Ghaedi and Mehri Salari and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Masoud Etemadifar

250 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masoud Etemadifar Iran 27 1.9k 729 592 565 542 262 3.5k
Simon Broadley Australia 30 1.8k 1.0× 1.2k 1.6× 519 0.9× 492 0.9× 563 1.0× 108 3.3k
Bonnie I. Glanz United States 31 2.2k 1.1× 732 1.0× 313 0.5× 704 1.2× 566 1.0× 110 3.3k
Maura Pugliatti Italy 39 2.2k 1.1× 787 1.1× 719 1.2× 658 1.2× 552 1.0× 157 4.3k
Adam E. Handel United Kingdom 27 1.6k 0.8× 486 0.7× 818 1.4× 869 1.5× 341 0.6× 85 3.9k
Kathryn C. Fitzgerald United States 38 1.7k 0.9× 878 1.2× 449 0.8× 715 1.3× 390 0.7× 161 4.2k
Giulio Disanto United Kingdom 35 3.4k 1.8× 1.3k 1.7× 808 1.4× 980 1.7× 556 1.0× 93 5.4k
Eleonora Cocco Italy 32 2.1k 1.1× 746 1.0× 641 1.1× 726 1.3× 506 0.9× 238 4.1k
Tobias Ruck Germany 34 1.1k 0.6× 1000 1.4× 819 1.4× 833 1.5× 340 0.6× 184 4.0k
Trygve Holmøy Norway 36 2.3k 1.2× 788 1.1× 1.2k 2.1× 515 0.9× 470 0.9× 170 3.8k
Stephen Lake United States 28 2.1k 1.1× 772 1.1× 964 1.6× 1.1k 2.0× 705 1.3× 66 5.6k

Countries citing papers authored by Masoud Etemadifar

Since Specialization
Citations

This map shows the geographic impact of Masoud Etemadifar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masoud Etemadifar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masoud Etemadifar more than expected).

Fields of papers citing papers by Masoud Etemadifar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masoud Etemadifar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masoud Etemadifar. The network helps show where Masoud Etemadifar may publish in the future.

Co-authorship network of co-authors of Masoud Etemadifar

This figure shows the co-authorship network connecting the top 25 collaborators of Masoud Etemadifar. A scholar is included among the top collaborators of Masoud Etemadifar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masoud Etemadifar. Masoud Etemadifar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Salari, Mehri, et al.. (2025). Epidemiology and clinical features of Huntington's disease in MENASA region: A systematic review and meta-analysis. Journal of Huntington s Disease. 14(4). 319–330.
2.
Etemadifar, Masoud, et al.. (2024). Optic neuritis following COVID-19 vaccination: Case series and review of the literature. Journal Français d Ophtalmologie. 47(8). 104264–104264. 1 indexed citations
3.
Salari, Mehri, et al.. (2023). Neuromyelitis optica spectrum disorder in a patient with ankylosing spondylitis: A case report. SHILAP Revista de lepidopterología. 11(6). e7556–e7556. 1 indexed citations
4.
Salari, Mehri, et al.. (2022). Manganese‐induced parkinsonism responsive to intranasal insulin: A case report. SHILAP Revista de lepidopterología. 10(3). e05562–e05562. 2 indexed citations
5.
Etemadifar, Masoud, Hosein Nouri, Mehri Salari, & Nahad Sedaghat. (2022). Detection of anti-NMDA receptor antibodies following BBIBP-CorV COVID-19 vaccination in a rituximab-treated person with multiple sclerosis presenting with manifestations of an acute relapse. Human Vaccines & Immunotherapeutics. 18(1). 2033540–2033540. 9 indexed citations
6.
Salari, Mehri, et al.. (2022). Atypical parkinsonism can be a presenting feature of late‐onset Huntington's disease. SHILAP Revista de lepidopterología. 10(7). e6014–e6014. 1 indexed citations
7.
Salari, Mehri, Anthony E. Lang, Leila Dargahi, Seyed Amir Hassan Habibi, & Masoud Etemadifar. (2021). Irreversible extreme freezing of gait after dopamine agonist withdrawal. SHILAP Revista de lepidopterología. 9(8). e04712–e04712. 1 indexed citations
8.
Zare, Hossein, et al.. (2018). Evaluating the effectiveness of cognitive rehabilitation on everyday memory in multiple sclerosis patients. Neuropsychological Rehabilitation. 30(6). 1013–1023. 6 indexed citations
9.
Etemadifar, Masoud, et al.. (2018). Impact of clinical mat pilates on body composition and functional indices in female patients with multiple sclerosis.. 5(4). 297–305. 9 indexed citations
10.
Ganjalıkhani-Hakemi, Mazdak, et al.. (2018). Semaphorin-3A as An Immune Modulator Is Suppressed by MicroRNA-145-5p. SHILAP Revista de lepidopterología. 13 indexed citations
11.
Alsahebfosoul, Fereshteh, et al.. (2017). Interleukin-33 plasma levels in patients with relapsing-remitting multiple sclerosis. BioMolecular Concepts. 8(1). 55–60. 22 indexed citations
12.
Etemadifar, Masoud, et al.. (2016). Health promotion behaviors and its correlation with some of the demographic factors in patients with multiple sclerosis. Advances in nursing and midwifery. 26(93). 11–18. 2 indexed citations
13.
Khosravi, Elham, et al.. (2014). The relationship of concentrations of lead and zinc and multiple sclerosis in Isfahan Province, Iran.. 32(275). 3 indexed citations
14.
Chitsaz, Ahmad, et al.. (2013). Does levetircetam decrease of the rubral tremor in patients with multiple sclerosis. SHILAP Revista de lepidopterología. 3 indexed citations
15.
Fereidan-Esfahani, Mahboobeh, et al.. (2013). Vitamin D: Shining A Light on Clinical and Sex Specific Effects in Multiple Sclerosis?. SHILAP Revista de lepidopterología. 1 indexed citations
16.
Etemadifar, Masoud, Seyed-Hossein Abtahi, Hassan Razmjoo, et al.. (2012). 25-hydroxyvitamin D Concentrations in Patients with Optic Neuritis as a Clinically Isolated Syndrome and Healthy Controls. SHILAP Revista de lepidopterología. 5 indexed citations
17.
Etemadifar, Masoud, et al.. (2011). The Relationship between Pain Self-efficacy and Pain intensity in Multiple Sclerosis Patients. International behavioral sciences/International journal of behavioral sciences. 5(1). 47–54. 5 indexed citations
18.
Etemadifar, Masoud, et al.. (2010). Associated Factors with Swallowing Disorders in Patients with Multiple Sclerosis. 28(104). 40–46. 3 indexed citations
19.
Etemadifar, Masoud, et al.. (2009). Comparing Side effects of CinnoVex with Avonex in Relapsing Remitting Multiple Sclerosis Patients. SHILAP Revista de lepidopterología. 5 indexed citations
20.
Etemadifar, Masoud, et al.. (2006). DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF JUVENILE MYOCLONIC EPILEPSY IN ISFAHAN/IRAN. SHILAP Revista de lepidopterología. 8(2). 160–164. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026